Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

Share Price is delayed by 15 minutes
Get Live Data
19.25    0.00 (0.00%)
Bid:
18.50
Ask:
20.00
Spread: 1.50 (8.108%)
Market Cap: £44.16m
GELN Live PriceLast checked at - London Stock Exchange

Intraday Gelion Share Chart

Block Admission Return

27 Jan 2026 08:02

RNS Number : 5187Q
Gelion PLC
27 January 2026
Β 

27 January 2026

Gelion plc

("Gelion" or the "Company")

Block Admission Return

The Company provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

Β 

a

Name of company

Β 

Gelion plc

b

Name of scheme

Β 

Gelion plc scheme: Shares

Β 

Existing Share Option Plan 8,100,000

Β 

c

Period of return (from/ to)

Β 

26 July 2025 to 26 January 2026

d

Number and Class of Securities not issued at the start of the period under the schemeΒ 

7,872,940 ordinary shares of 0.1p each

e

Additional listing

Nil

f

Number of securities issued under the scheme during the period

Β 

Shares

Existing Share Option Plan 69,673

g

Balance under the scheme of securities not yet issued at the end of the period

Β 

Shares

Existing Share Option Plan 7,803,267

Β 

Β 

h

Number and class of securities originally admitted and the date of admission

8,100,000 ordinary shares of 0.1p each

Β 

i

Contact name - CompanyΒ 

Telephone number

Β 

Contact name - Strand Hanson Limited

Telephone number

Amit Gupta

+44 (0) 20 3405 0205

Β 

Christopher RaggettΒ 

+44 (0) 20 7409 3494

Β 

CONTACTS

Gelion plc

John Wood, CEO

Amit Gupta, CFO

Β 

via Alma

Strand Hanson LimitedΒ (Nominated and Financial Adviser)

Christopher Raggett / Rob Patrick / Harry Marshall

Β 

Oberon CapitalΒ (Joint Broker)

Nick Lovering / Mike Seabrook / Adam Pollock

+44 (0) 20 7409 3494

Β 

+44 (0) 20 3179 5300

Β 

Β 

Allenby Capital LimitedΒ (Joint Broker)

Jos Pinnington / Lauren Wright (Sales and Corporate Broking)

Alex Brearley / Ashur Joseph (Corporate Finance)

Β 

Β 

Β 

+44 (0) 20 3328 5656

Alma Strategic Communications (Financial PR Adviser)

Justine James / Hannah Campbell / Rose Docherty

Β 

+44 (0) 20 3405 0205

gelion@almastrategic.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCAKOBKFBKKBDB
Date   Source Headline
4th Jun 202612:53 pmRNS-RPublication of Research Report
2nd Jun 20267:00 amRNSNissan Project, Grant Award, Investor Presentation
21st May 20267:00 amRNSHolding(s) in Company
13th Apr 20267:00 amRNS-RQ1 2026 Newsletter
31st Mar 20267:00 amRNSExceptional Technical Results
3rd Mar 20268:32 amRNSDirector/PDMR Shareholding - Grant of options
2nd Mar 20267:00 amRNSHalf year results to 31 December 2025
11th Feb 20267:00 amRNSBusiness Update, Notice of Results & IMC
4th Feb 20267:00 amRNSChange of Registered Office
27th Jan 20268:02 amRNSBlock Admission Return
15th Jan 20267:00 amRNSProf. Rachid Yazami Appointed Technology Advisor
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
24th Dec 20259:24 amRNSDirector Dealing
24th Dec 20259:24 amRNSDirector Dealing
22nd Dec 202512:18 pmRNSResult of AGM
22nd Dec 202512:18 pmRNSResult of AGM
11th Dec 20257:00 amRNS-RChange of Name of OXLiD Ltd to Gelion Europe Ltd
10th Dec 20258:59 amRNSDirector/PDMR Shareholding - Grant of Options
4th Dec 20257:00 amRNSGelion Achieves Key Industry Technical Milestone
27th Nov 20257:01 amRNSNotice of AGM
27th Nov 20257:00 amRNSFinal results to 30 June 2025
25th Nov 20258:30 amRNSNotice of Results and Investor Presentation
5th Nov 20259:21 amRNSResult of GM, PDMR Dealings & Total Voting Rights
29th Oct 20257:00 amRNS-RGeneral Meeting Information
21st Oct 20257:00 amRNSResult of Oversubscribed WRAP Retail Offer
21st Oct 20257:00 amRNSFull Collaboration Agreement with TDK
20th Oct 20254:30 pmRNSEarly Close of WRAP Retail Offer
17th Oct 202510:34 amRNSResult of Placing and Subscription
16th Oct 20255:30 pmRNSWRAP Retail Offer for up to £500k
16th Oct 20254:43 pmRNSProposed Placing, Subscription & Retail Offer
16th Oct 20254:35 pmRNSSulfur CAM: Drop-In for Existing Battery Plants
16th Oct 20254:35 pmRNSThree Li-S Patents Advance Successfully in U.S.
16th Oct 20254:35 pmRNSCollaboration with Tier-One Battery Partner
19th Sep 20257:30 amRNSOXLiD funding for Li-S project with QinetiQ
15th Sep 20257:00 amRNSHigh Lithium Recovery at Battery Minerals Ltd
3rd Sep 20257:00 amRNSSuccessful MPI Tech Transfer & Sulfur CAM Scale-Up
5th Aug 20257:00 amRNSGelion Achieves Breakthrough in Li-S Performance
1st Aug 20257:00 amRNSNotification of Major Holdings
28th Jul 20257:00 amRNSBlock Admission Return
14th Jul 20257:00 amRNSGrant Funding & Commissioning of Prototyping Line
8th Jul 20257:00 amRNSCommencement of £2.3m Australian Government Grant
1st Jul 20257:00 amRNSSuccessful Installation of 4-MWh BESS
26th Jun 20257:07 amRNSStrong Progress at Battery Minerals
5th Jun 20259:16 amRNSHolding(s) in Company
5th Jun 20259:15 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDirector Holdings
20th May 20257:00 amRNSDirector Dealing
6th May 20254:07 pmRNSResult of GM, PDMR Dealings & Total Voting Rights
30th Apr 202511:42 amRNSDirector/PDMR Shareholding - Grant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.